The Data Migration Factory
With more than 150 migrations focused on system implementations behind us, we have followed our customers on their journeys to leverage acquisitions and CRO collaboration for faster innovation and drug development. This spurred the Migration Factory offering.
Whether you have acquired a single drug or a clinical stage biotech, are reclaiming trial data from a CRO, or have acquired a factory to expand production capacity, a constant influx of data gives you an opportunity to lower cost, decrease timelines, lower risk, and still keep quality high and ensure you are ready for submissions, inspections, or ramping up production. This is what a migration factory gives you.
Leveraging our best-in-class approach and adding AI on top
BASE life science has been one of Veeva’s premier data migration partners since 2019. A Data Migration Factory builds on top of our approach, people, and tools by making them specific to your unique needs and then standardizing even further to harvest gains while maintaining and potentially increasing quality.
On top of that, we have started using AI in our Migration Factories – from personal productivity to AI driven field mapping implementation to complete metadata extraction and enrichment, coming in at 90% accuracy.
Skin in the game
Our customers’ ways of working are as diverse as the diseases they treat, but everyone deserves a data migration partner that lives up to their promises. We offer T&M, fixed price, but also outcome-based pricing. We want to succeed with you. We want to set up for the long term, and we know that requires skin in the game.
From one-off projects to a lasting capability
BASE life science White Paper
Every migration shouldn’t start from scratch. In this white paper, Ulrik Oppenlaender explains how a Data Migration Factory turns a series of migrations into a repeatable, increasingly efficient capability, built on reusable tools and infrastructure, standardized mappings and validation, and a team that already knows your people and processes.
The result is up to 56% lower cost per document and timelines that are 1–2 months shorter. Written for clinical, regulatory, quality and IT teams planning Veeva migrations after acquisitions or from CROs.
Read the White Paper
